Connect Common Stock Shares Outstanding vs Capital Lease Obligations Analysis
| CNTB Stock | USD 1.78 0.06 3.49% |
Connect Biopharma financial indicator trend analysis is way more than just evaluating Connect Biopharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Connect Biopharma is a good investment. Please check the relationship between Connect Biopharma Common Stock Shares Outstanding and its Capital Lease Obligations accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.
Common Stock Shares Outstanding vs Capital Lease Obligations
Common Stock Shares Outstanding vs Capital Lease Obligations Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Connect Biopharma Common Stock Shares Outstanding account and Capital Lease Obligations. At this time, the significance of the direction appears to have very week relationship.
The correlation between Connect Biopharma's Common Stock Shares Outstanding and Capital Lease Obligations is 0.22. Overlapping area represents the amount of variation of Common Stock Shares Outstanding that can explain the historical movement of Capital Lease Obligations in the same time period over historical financial statements of Connect Biopharma Holdings, assuming nothing else is changed. The correlation between historical values of Connect Biopharma's Common Stock Shares Outstanding and Capital Lease Obligations is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock Shares Outstanding of Connect Biopharma Holdings are associated (or correlated) with its Capital Lease Obligations. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Capital Lease Obligations has no effect on the direction of Common Stock Shares Outstanding i.e., Connect Biopharma's Common Stock Shares Outstanding and Capital Lease Obligations go up and down completely randomly.
Correlation Coefficient | 0.22 |
| Relationship Direction | Positive |
| Relationship Strength | Very Weak |
Common Stock Shares Outstanding
The total number of shares of a company's common stock that are currently owned by all its shareholders.Capital Lease Obligations
Connect Biopharma capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Connect Biopharma asset purchases. For example, Connect Biopharma can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Connect Biopharma control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Most indicators from Connect Biopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Connect Biopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. At present, Connect Biopharma's Enterprise Value Over EBITDA is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.27, whereas Tax Provision is forecasted to decline to about 114 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 4.1M | 6.9M | 988K | 938.6K | Total Operating Expenses | 621.5M | 785.2M | 64.8M | 61.6M |
Connect Biopharma fundamental ratios Correlations
Click cells to compare fundamentals
Connect Biopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Connect Biopharma fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Other Current Liab | 4.2M | 12.8M | 32.8M | 24.4M | 3.0M | 2.8M | |
| Total Current Liabilities | 27.4M | 38.0M | 114.7M | 108.8M | 24.3M | 23.1M | |
| Retained Earnings | (292.1M) | (1.1B) | (2.4B) | (3.2B) | (539.3M) | (566.3M) | |
| Accounts Payable | 22.8M | 24.6M | 81.2M | 83.1M | 7.7M | 7.3M | |
| Net Receivables | 1.2M | 1.7M | 47.3M | 1.6M | 178K | 169.1K | |
| Other Stockholder Equity | 42.5M | 48.1M | 4.2B | (71.2M) | 648.3M | 876.5M | |
| Total Current Assets | 362.8M | 1.1B | 1.8B | 1.1B | 121.0M | 114.9M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Connect Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Connect Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Connect Biopharma Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Connect Biopharma Holdings Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Connect Biopharma Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Complementary Tools for Connect Stock analysis
When running Connect Biopharma's price analysis, check to measure Connect Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Connect Biopharma is operating at the current time. Most of Connect Biopharma's value examination focuses on studying past and present price action to predict the probability of Connect Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Connect Biopharma's price. Additionally, you may evaluate how the addition of Connect Biopharma to your portfolios can decrease your overall portfolio volatility.
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Connect Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Connect Biopharma. If investors know Connect will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Connect Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.08) | Return On Assets (0.27) | Return On Equity (0.46) |
The market value of Connect Biopharma is measured differently than its book value, which is the value of Connect that is recorded on the company's balance sheet. Investors also form their own opinion of Connect Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Connect Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Connect Biopharma's market value can be influenced by many factors that don't directly affect Connect Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Connect Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Connect Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Connect Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.